Ageing of the hypothalamo-pituitary-testicular axis in men

Hormone Research in Paediatrics

Volumn 43, Issue 1-3, 1995, Pages 25-28

  Vermeulen, A ^a   Kaufman, J M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Ageing; Gonadotropins; Hypothalamus; Luteinizing hormone pulsatility; Pituitary; Testis; Testosterone

Indexed keywords

ANDROGEN; GONADORELIN; LUTEINIZING HORMONE; TESTOSTERONE; HORMONE;

AGING; BONE METABOLISM; CONFERENCE PAPER; DEPRESSION; DIET; ENDURANCE; FERTILITY; FITNESS; GONADORELIN RELEASE; HEMATOCRIT; HEREDITY; HORMONE SUBSTITUTION; HUMAN; HYGIENE; HYPOPHYSIS GONAD SYSTEM; LEYDIG CELL; LUTEINIZING HORMONE RELEASE; MALE; MUSCLE STRENGTH; NERVE CELL; OBESITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; RISK; SERTOLI CELL; SMOKING; SPERMATOGENESIS; STRESS; TESTIS; TESTOSTERONE BLOOD LEVEL; ADULT; AGED; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PHYSIOLOGY; REVIEW;

ADULT; AGED; AGING; ANDROGENS; HORMONES; HUMAN; HYPOGONADISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEYDIG CELLS; LUTEINIZING HORMONE; MALE; MIDDLE AGE; TESTIS;

EID: 0028979570     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000184233     Document Type: Article

References (31)

1. Vermeulen A: Androgens and male senescence; in Nieschlag E, Behre AM (eds): Testosterone – Action, Deficiency, Substitution. Berlin, Springer, 1990, pp 261–274.
2. Vermeulen A, Stoïca T, Verdonck L: The apparent free testosterone concentration, an index of androgenicity. J Clin Endocrinol Metab 1971;33:759–767.
3. Pirke M, Doerr P: Age related changes and interrelationship between plasma testosterone, estradiol and testosterone binding globulin in normal adult males. Acta Endocrinol 1973;74:792–800.
4. Schwarz D, Mayaux MJ, Spira A, Moscato M, Jouannet P, Czyglik F, David G: Semen characteristics as a function of age in 833 fertile men. Fertil Steril 1983;39:530–535.
5. Mineau CP, Trussel L: A specification of marital fertility by parents age at marriage and marital duration. Demography 1982;19:335–349.
6. Sniffen RC: The testes. I. The normal testis. Arch Pathol 1950;50:259–284.
7. Neaves WB, Johnson L, Parker CR, Petty CS: Leydig cell numbers, daily sperm production and gonadotrophin levels in aging men. J Clin Endocrinol Metab 1984;49:756–763.
8. Harbitz TB: Morphometric studies of Leydig cells in elderly men, with special reference to the histology of the prostate. Acta Pathol Microbiol Scand 1973;81:301–313.
9. Longcope C: The effect of human chorionic gonadotropin on plasma levels in young and old men. Steroids 1973;21:583–590.
10. Nieschlag E, Kley KH, Wiegelman W, Solbach HG, Krüskemper HL: Lebensalter und endokrine Funktion des erwachsenen Mannes. Dtsch Med Wochenschr 1973;98:1281–1284.
11. Rubens R, Dhont M, Vermeulen A: Further studies on Leydig cell function in old age. J Clin Endocrinol Metab 1984;39:40–45.
12. Sasano M, Ishijo S: Vascular patterns of the human testis with special reference to its senile changes. Tohoku J Exp Med 1969;99:269–280.
13. Suoranta H: Changes in small vessels of the adult testes in relation to age and some pathological conditions. Virchows Arch A Pathol Anat Histopathol 1971;352:765–781.
14. Johnson L, Petty CS, Neaves WB: Age related variations in seminiferous tubules in men. A stereologic evaluation. J Androl 1986;7:316–322.
15. Kaufman JM, Giri M, Deslypere JP, Thomas G, Vermeulen A: Influence of age on the responsiveness of the gonadotrophs to luteinizing hormone-releasing hormone in males. J Clin Endocrinol Metab 1991;72:221–224.
16. Bremner WJ, Vitiello MV, Prinz PN: Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983;56:1278–1281.
17. Deslypere JP, Vermeulen A: Leydig cell function in normal men: Effect of age, life style, residence diet and activity. J Clin Endocrinol Metab 1984;59:955–962.
18. Nankin HR, Murono E, Lin T et al: Morning and evening human Leydig cell response to hCG. Acta Endocrinol 1990;95:560–565.
19. Winter SJ, Sherins RJ, Troen P: The gonadotropin suppressive activity of androgen is increased in elderly men. Metabolism 1984;33:1052–1059.
20. Deslypere JP, Kaufman JM, Vermeulen T, Vogelaers D, van Dalem JL, Vermeulen A: Influence of age of pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men. J Clin Endocrinol Metab 1987;64:68–73.
21. Vermeulen A, Deslypere JP, Kaufman JM: Influence of antiopioids on luteinizing hormone pulsatility in aging men. J Clin Endocrinol Metab 1989;68:68–72.
22. Vermeulen A, Kaufman JM, Deslypere JP, Thomas G: Attenuated LH pulse amplitude but normal LH pulse frequency and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab 1993;76:1140–1146.
23. Veldhuis JD, Urban RJ, Lizzaralde G, Johnson ML, Iranmanesh A: Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis of hypoandrogenism of healthy aging men. J Clin Endocrinol Metab 1992;75:52–58.
24. Meikle AW, Stanish WM, Taylor N, Edwards CQ, Bishop CT: Familial effects on plasma sex steroid content in men: Testosterone, estradiol and sex hormone binding globulin. Metabolism 1982;31:6–10.
25. Meikle AW, Stringham JD, Bishop DT, West DW: Quantitating genetic and nongenetic factors influencing androgen production and clearance rate in men. J Clin Endocrinol Metab 1988;67:104–109.
26. Cameron JL, Weltzin TE, McConaha C, Helmreich DL, Kaye WH: Slowing of pulsatile luteinizing hormone secretion in men after forty-eight hours of fasting. J Clin Endocrinol Metab 1991;73:35–41.
27. Reiter T: Testosterone implantation: A clinical study of 240 implantations in aging males. J Am Geriatr Soc 1963;11:540–550.
28. Matsumoto AM: Effects of chronic testosterone administration in normal men: Safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone. follicle stimulating hormone and sperm production. J Clin Endocrinol Metab 1990;70:282–287.
29. Tenover JS: Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1990;75:1092–1095.
30. Jackson JA, Waxman J, Spiekerman M: Prostatic implications of testosterone replacement therapy. Arch Intern Med 1989;149:2364–2366.
31. Schröder FH: Androgens and carcinoma of the prostate; in Nieschlag E, Behre HM (eds): Testosterone – Action, Deficiency, Substitution. Berlin, Springer, 1990, pp 245–260.